Comparison of T2-weighted imaging, DWI, and dynamic contrast-enhanced MRI for calculation of prostate cancer index lesion volume: correlation with whole-mount …

C Sun, A Chatterjee, A Yousuf, T Antic… - American Journal of …, 2019 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to investigate the comparative effectiveness of
different MRI sequences for the estimation of index lesion volume in patients with prostate …

[HTML][HTML] Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis

HS Park, JD Schoenfeld, RB Mailhot, M Shive… - Annals of oncology, 2013 - Elsevier
Background In this meta-analysis, we evaluated associations between statins and
recurrence-free survival (RFS) following treatment of localized prostate cancer, with attention …

Health-related quality of life in prostate cancer

S Torvinen, N Färkkilä, H Sintonen, T Saarto… - Acta …, 2013 - Taylor & Francis
Background. With new treatment options, the prognosis of prostate cancer (PCa) has
improved in recent decades, and health-related quality of life (HRQoL) has become an …

[HTML][HTML] Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database

LM Burt, DC Shrieve, JD Tward - Advances in radiation oncology, 2018 - Elsevier
Purpose The aim of this study is to describe the trends and factors that influence the initial
treatment of men with localized prostate cancer (PC) in the United States between 2004 and …

Radical prostatectomy versus deferred treatment for localised prostate cancer

RWM Vernooij, M Lancee, A Cleves… - Cochrane Database …, 2020 - cochranelibrary.com
Background Prostate cancer is a common cancer but is oftentimes slow growing. When
confined to the prostate, radical prostatectomy (RP), which involves removal of the prostate …

A core outcome set for localised prostate cancer effectiveness trials

S MacLennan, PR Williamson, H Bekema… - BJU …, 2017 - Wiley Online Library
Objective To develop a core outcome set (COS) applicable for effectiveness trials of all
interventions for localised prostate cancer. Many treatments exist for localised prostate …

Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011

SM Evans, JL Millar, ID Davis… - Medical journal of …, 2013 - Wiley Online Library
Objective: To describe patterns of care for men diagnosed with prostate cancer in Victoria,
Australia, between 2008 and 2011. Design, setting and patients: Men who were diagnosed …

Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics

JA March-Villalba, JM Martínez-Jabaloyas, MJ Herrero… - 2012 - journals.plos.org
Background Serum prostate-specific antigen (PSA) is the most widely used marker for
diagnosing prostate cancer (PCa). It lacks specificity and predictive value, resulting in …

[HTML][HTML] Assessing the acceptability and usability of an interactive serious game in aiding treatment decisions for patients with localized prostate cancer

L Reichlin, N Mani, K McArthur, A Harris… - Journal of medical …, 2011 - jmir.org
Background: Men diagnosed with localized prostate cancer face a potentially life-altering
treatment decision that can be overwhelming. Enhancing patient knowledge through …

Cost‐effectiveness analysis of intensity‐modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer

AT Zemplényi, Z Kaló, G Kovács… - European Journal of …, 2018 - Wiley Online Library
The aim of our analysis was to compare the cost‐effectiveness of high‐dose intensity‐
modulated radiation therapy (IMRT) and hypofractionated intensity‐modulated radiation …